ANTI-ERBB3 ANTIBODIES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230365710A1
SERIAL NO

18307638

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Monoclonal antibodies that bind and inhibit activation of epidermal growth factor receptor related member ErbB3/IER3 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation of ErbB3/HER3.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVEO PHARMACEUTICALS INC75 SIDNEY STREET 4TH FLOOR CAMBRIDGE MA 02139

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bottega, Steve Cambridge, US 10 43
Breault, Lyne Roslindale, US 19 231
Chen, Ting Acton, US 211 4505
DePrima, Michael Somerville, US 6 64
Fleet, Christina Melrose, US 6 64
Gyuris, Jeno Lincoln, US 63 604
Meetze, Kristan Lexington, US 22 178
Tyler, Steven Boston, US 23 672
VINCENT, Sylvie Somerville, US 10 85
Wang, Fang Belmont, US 312 3140
Weiler, Solly Newton, US 17 213
Winston,, JR William M Marlborough, US 32 270
Woo, Jin-Kyeung Newton, US 6 64

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation